Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

NCT00957047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsy

Interventions

DRUG: eslicarbazepine acetate
DRUG: placebo
DRUG: ESL - Part II

Sponsor

Bial - Portela C S.A.